Author

Guilherme Lopes

Observed name: G. d. Lopes

Institution: Faculdade de Medicina do ABC

Observed institutions: Mayo Clinic, Faculdade de Medicina do ABC

OpenAlex ID: A5044734810

A phase II trial of nab-paclitaxel (NP) in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine (G)-based therapy.

2010 · P. J. Hosein, G. d. Lopes, et al. · Journal of Clinical Oncology · 11

Evaluating longitudinal toxicity of cetuximab in patients with metastatic colorectal cancer (mCRC): A pooled analysis from 1,302 patients in the ARCAD database.

2021 · Guilherme Lopes, Jane Yeojeong So, et al. · Journal of Clinical Oncology · 3

How to improve toxicity evaluation in clinical trials? Testing new metrics from irinotecan or oxaliplatin-based treatments in metastatic colorectal cancer (mCRC): A pooled analysis from 2,349 patients in ARCAD database.

2020 · Christophe Tournigand, Guilherme Lopes, et al. · Journal of Clinical Oncology · 1

Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis

2026 · Skyler Taylor, Isadora Mamede, et al. · JTO Clinical and Research Reports

Works count: 4

Citation count: 15

H-index: 2

I10-index: 1